Healthcare & Pharmaceuticals SEC Filings — 2026

Pharmaceuticals, biotech, medical devices, and health services companies In 2026, healthcare & pharmaceuticals companies filed regulatory disclosures with the SEC including annual reports, quarterly updates, insider transactions, and material event notifications.

500 total filings across 38 form types.

Filing Types in 2026

Latest Filings (30)

Frequently Asked Questions

How many SEC filings did healthcare & pharmaceuticals companies make in 2026?

Healthcare & Pharmaceuticals companies filed 500 SEC filings in 2026. The most common types were 8-K (152), 6-K (70), 4 (47).

What types of SEC filings do healthcare & pharmaceuticals companies file?

Healthcare & Pharmaceuticals companies file 10-K annual reports, 10-Q quarterly reports, 8-K current reports, Form 4 insider disclosures, 13F-HR institutional holdings, S-1 IPO registrations, and more.

How can I track healthcare & pharmaceuticals filing trends in 2026?

Read The Filing provides AI-powered summaries, risk assessments, and sentiment analysis for every healthcare & pharmaceuticals SEC filing. You can browse by form type, compare companies, and track monthly patterns.

View on Read The Filing